Scarica l'app Stockscreener
234.40
0.69%
-1.64
Dopo l'orario di chiusura:
234.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$236.04
Aprire:
$235.82
Volume 24 ore:
541.74K
Relative Volume:
0.60
Capitalizzazione di mercato:
$25.87B
Reddito:
$11.28B
Utile/perdita netta:
$1.07B
Rapporto P/E:
25.86
EPS:
9.0657
Flusso di cassa netto:
$1.33B
1 W Prestazione:
-1.66%
1M Prestazione:
+13.79%
6M Prestazione:
+13.31%
1 anno Prestazione:
+31.36%
Intervallo 1D:
$233.69
$237.69
Intervallo di 1 settimana:
$232.28
$240.00
Portata 52W:
$171.18
$240.13
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
234.40 | 26.24B | 11.28B | 1.07B | 1.33B | 9.0657 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Ripresa | Evercore ISI | In-line |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-29 | Iniziato | Piper Sandler | Neutral |
| 2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-01-23 | Iniziato | Evercore ISI | In-line |
| 2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-23 | Downgrade | UBS | Buy → Neutral |
| 2022-02-02 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
| 2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Downgrade | Goldman | Neutral → Sell |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-03-18 | Ripresa | Credit Suisse | Neutral |
| 2019-01-31 | Downgrade | Argus | Buy → Hold |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Carol Devine Miller sells stocks in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp - Investing.com South Africa
Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know - Yahoo Finance
T. Rowe Price Associates (DGX) discloses 5.43M Quest Diagnostics shares in 13G/A - Stock Titan
Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86 - MarketBeat
Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Q2 2026 Quest Diagnostics Inc Earnings Call Transcript - GuruFocus
Rep. Carol Miller's household sold Pfizer, Quest, Target, and U.S. Bancorp 521 days before disclosure - 24/7 Wall St.
Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6 - marketscreener.com
Quest Diagnostics Declares Quarterly Cash Dividend - marketscreener.com
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on October 21, 2026 - marketscreener.com
Diversified Management Inc. Lowers Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC - MarketBeat
Quest Diagnostics Inc (DGX) Stock News Today - TradingKey
Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results? - Yahoo Finance
Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises - Yahoo Finance
Arrowstreet Capital Limited Partnership Purchases New Shares in Quest Diagnostics Incorporated $DGX - marketbeat.com
Quest Diagnostics Incorporated $DGX Shares Bought by Eastern Bank - MarketBeat
Royal Bank of Canada Has $38.91 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates - The Globe and Mail
Bank of America Corp DE Acquires 129,964 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Cetera Investment Advisers Acquires 8,362 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
California State Teachers Retirement System Sells 5,763 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Alpine Woods Capital Investors LLC Cuts Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Sei Investments Co. Increases Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
PR News | On the Move: Quest Diagnostics Names Chokshi IR ChiefThu., Jul. 30, 2026 - O'Dwyer's PR
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics - morningstar.com
Quest Diagnostics Incorporated $DGX Shares Sold by Lazard Asset Management LLC - MarketBeat
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $248.86, Implies 6% Upside - TradingView
OMERS ADMINISTRATION Corp Buys 10,073 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Insider at DGX (NYSE: DGX) plans sale of 1,600 common shares - Stock Titan
JPMorgan Adjusts Price Target on Quest Diagnostics to $250 From $220, Maintains Neutral Rating - marketscreener.com
DGX|Quest Diagnostics Inc|Price:231.750|Chg%:+3.890 - TradingKey
EdgePoint Investment Group Inc. Buys 582,797 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc (DGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 Quest Diagnostics orporated For: 28 July By Investing.com - Investing.com South Africa
Quest Diagnostics Inc (DGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics (NYSE: DGX) SVP adds shares via dividend reinvestment plan - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP acquires 34.0000 shares via dividend reinvestment - Stock Titan
Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating - Moomoo
Quest Diagnostics (DGX) Leads S&P 500 Healthcare Gainers with 8. - GuruFocus
Quest Diagnostics Incorporated (DGX) Stock forecasts - Yahoo Finance Singapore
Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks - Yahoo Finance
Quest Diagnostics stock trades steady as earnings and diagnostics demand shape investor focus - Ad-hoc-news.de
Quest Diagnostics Inc (DGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quest Diagnostics Inc (DGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):